跳至主要内容
临床试验/KCT0006605
KCT0006605已完成未知

A 12 weeks, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Gastrodia elata Blume extract on improvement of Cognitive Function

Wonkwang University. Iksan Korean Medicine Hospital0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
45(Year) 至 65(Year)(—)
性别
All

入选标准

  • 1) Males and females aged 45-65 years over at the screening examination
  • 2) Participants who have mini mental state examination score of 20 to 28.
  • 3) Participants who have fully understand the information provided about the study voluntarily decided to participate and agree to comply with precautions.

排除标准

  • 1) The patients who have a history of alcoholism dependency/abuse within the last 3 months before the screening examination.
  • 2) The patients who take medicine, health functional foods or oriental medicine within the last 1 month before the screening examination.
  • 3) Patients who have participated in other clinical trials within the last 3 months before the screening examination.
  • 4) Patients who have laboratory test outcomes as follow.
  • ? AST(Aspartate aminotransferase), ALT(Alanine Transaminase) > three times the normal limit
  • ? Serum Creatinine > 2.0 mg/dL
  • 5) Patients who are judged ineligible to participate in the trial by the principal investigator for other reasons, including laboratory test outcomes.

研究者

发起方
Wonkwang University. Iksan Korean Medicine Hospital

相似试验